Introduction
Laminins, αβγ trimeric glycoproteins, are major components of basement membranes (BMs) that play crucial roles in transmitting BM signals to cells. Various cellular processes including adhesion, migration, survival, proliferation, and differentiation are supported by laminins through interactions with cell-surface receptors. The most important receptors for sensing laminin signals are integrins, which are αβ dimeric cell-surface transmembrane proteins.
There are several modes of laminin-integrin interactions. One of the integrin-binding sites in laminins is located in a C-terminal αβγ complex known as the E8 fragment (Sonnenberg et al, 1990) . The E8 fragments of laminins interact with multiple integrins, including α3β1, α6β1, α6β4, and α7β1 (Sonnenberg et al, 1990; Ido et al, 2007; Taniguchi et al, 2009) . It is known that αβγ trimer formation, LG1-3 domains of the α chain, and Glu residue in the γ1 chain C-terminal tail (γ1C-Glu) (Fig 1A) are prerequisites for the integrin-binding ability of E8 fragments (Sung et al, 1993; Ido et al, 2004 Ido et al, , 2007 Taniguchi et al, 2017) . Recently, the crystal structures of truncated E8 fragments derived from laminin-111 and laminin-511 were solved (Pulido et al, 2017; Takizawa et al, 2017) . The structures predicted that γ1C-Glu can bind directly to the metal ion-dependent adhesion site in the integrin β1 subunit. Thus, the biochemical significance of γ1C-Glu for integrin binding is apparent, but its physiological roles remain to be fully addressed.
Here, we investigated the physiological significance of γ1C-Glu for laminin-integrin interactions in vivo by generating a knock-in mouse strain in which γ1C-Glu was substituted with Gln. The resulting knock-in mice showed early postimplantation lethality, underscoring the critical role of γ1C-Glu-dependent lamininintegrin interactions for early embryonic development. Based on these findings, we established another knock-in mouse strain in which the γ1C Glu to Gln (EQ) mutation can be introduced on demand by the Cre-loxP system.
Results and Discussion
γ1 EQ mutation specifically abolishes laminin binding to α3, α6, and α7 integrins in vitro Before starting in vivo studies, we confirmed the impact of γ1C-Glu on integrin binding by laminins in vitro (Fig 1) . For this, we expressed and purified recombinant full-length laminin-111 and laminin-511 and their derivatives containing the EQ mutation ( Fig S1) . Because a panel of integrins including α1β1, α2β1, α3β1, α6β1, α6β4, α7β1, α9β1, αvβ3, and αvβ5 were reported to interact with these laminins (Forsberg et al, 1994; Pfaff et al, 1994; Sasaki & Timpl, 2001; Nishiuchi 1 et al, 2006) , we expressed these integrins as truncated soluble forms in mammalian cells. Integrin α5β1 was also included as a negative control. The recombinant integrins were assessed for their abilities to bind to the laminins and their EQ mutants by solidphase binding assays (Ido et al, 2007) .
Integrins α3β1, α6β1, α6β4, and α7x1β1 bound specifically to laminin-511, whereas integrin α7x2β1 bound to both laminin-111 and laminin-511 (Fig 1D-H) . Integrin α6β1 binding to recombinant laminin-111 was weak under the used condition (Fig 1E) , unlike in previous reports that used Engelbreth-Holm-Swarm (EHS) tumorderived mouse laminin-111 (Sonnenberg et al, 1990; Nishiuchi et al, 2003 Nishiuchi et al, , 2006 . When the coating concentration of laminin-111 was increased, integrin α6β1 was capable of binding to both mouse and human laminin-111 in a dose-dependent manner, but mouse laminin-111 had significantly more affinity than human recombinant laminin-111 for integrin α6β1 (Fig S2B) . Introduction of the γ1 EQ mutation abolished the abilities of laminin-111 and laminin-511 to bind to these integrins, consistent with our previous reports (Ido et al, 2007; Taniguchi et al, 2009) . Among the other integrins examined, two Arg-Gly-Asp (RGD)-binding integrins, αvβ3 and αvβ5, exhibited significant binding to laminin-511 and weaker binding to laminin-111, and this binding was not compromised by the γ1 EQ mutation (Fig 1J and K) . No binding to integrins α1β1, α2β1, α9β1, and α5β1 was observed (Figs 1B, C, I, L and S2A) . This comprehensive survey of the integrin-binding activities of full-length laminin-111 and laminin-511 and their EQ mutants clearly showed that γ1 laminins were susceptible to the γ1 EQ mutation for their interactions with classical laminin-binding integrins, that is, α3β1, α6β1, α6β4, and α7β1.
Generation of Lamc1
EQ mice and embryonic lethality
To evaluate the impact of the γ1 EQ mutation in vivo, we generated a γ1 EQ knock-in allele, Lamc1
EQ
, in which the codon encoding γ1C-Glu was mutated to introduce Gln (Fig 2A and B) . Although Lamc1 EQ/+ heterozygous mice were fertile and did not exhibit any developmental defects, no Lamc1 EQ/EQ neonates were obtained (Fig 2C) .
Because αβγ trimer formation is a prerequisite for efficient secretion of laminins (Yurchenco et al, 1997) , we examined whether laminins formed αβγ trimers in Lamc1 EQ/EQ mice. Protein extracts from Lamc1 EQ/EQ E7.5 embryos were subjected to SDS-PAGE under nonreducing conditions and immunoblotted with an anti-laminin antibody. Lamc1 EQ/EQ embryonic extracts produced a signal at~800 kD similar to the case for Matrigel, a laminin-111-rich mouse tumor extract ( Fig 2D) . These results confirmed that EQ mutant laminins were able to form αβγ trimers. To address whether both laminin-111 and laminin-511 with a mutated γ1 chain can be secreted normally, we expressed these laminins in human 293 cells, and conditioned media were subjected to SDS-PAGE under non-reducing conditions and subsequent immunoblotting. No significant difference was detected in the amounts of the secreted heterotrimers between laminin-111/-511 and their EQ-mutants (Fig S3) , suggesting that laminin-111 and laminin-511 with the mutated γ1 chain were secreted normally. Therefore, Lamc1 EQ/EQ mice were phenotypically different from Lamc1 −/− mice (Smyth et al, 1999) , because they expressed αβγ trimeric laminin, whereas Lamc1 −/− mice did not.
When E7.5 embryo sections were examined for binding of integrin α7x2β1, which can bind both laminin-111 and laminin-511 (Fig 1H) , WT and Lamc1 EQ/+ embryos showed specific integrin α7x2β1 binding in their laminin-positive BMs (Fig 2E) . Lamc1 EQ/EQ homozygotes were distinguished from the other embryos by the absence of this integrin binding (Fig 2F) . These results demonstrated that the γ1C-Glu-dependent integrin-binding activity of laminins was abolished by the γ1 EQ mutation in vivo.
To address the embryonic lethality of Lamc1 EQ/EQ mice, E7.5 egg cylinders were investigated morphologically by light microscopy or sectioned and examined by immunofluorescence. Because laminin-111 and laminin-511 are expressed in Reichert's membrane (RM) (Sasaki et al, 2002; Miner et al, 2004) , the parietal yolk sac, an extraembryonic tissue enveloping the egg cylinder, was visualized by its laminin-positive BM in sections of control WT/Lamc1 Collectively, Lamc1 EQ/EQ mice showed morphogenetic defects at the early postimplantation stage.
γ1C-Glu-dependent integrin binding is dispensable for BM deposition
To determine the timing for the morphological abnormality in Lamc1 EQ/EQ homozygotes, we investigated the development of preimplantation embryos. Before implantation (E4.0 and E4.3), formation of the blastocoel cavity and inner cell mass were comparable between WT and Lamc1 EQ/EQ blastocysts ( Fig 3A-H) . At E4.0, laminins were barely detected at the basal surface of the mural trophectoderm in blastocysts, irrespective of the genotypes (Fig 3A-D) . Similarly, perlecan, another BM component, was not detected in E4.0 blastocysts (Fig 3A and B) . In E4.3 blastocysts, laminins were detected at the basal surface of the mural trophectoderm in both WT and Lamc1 EQ/EQ blastocysts ( Fig 3E-H) .
Perlecan was also detected at the basal aspect of the mural trophectoderm in E4.3 blastocysts (Fig 3E and F) . Primitive endoderm cells, the main laminin-producing cells producing dense signals with an anti-laminin antibody, were recognized in both WT and Lamc1 EQ/EQ blastocysts (asterisks in Fig 3E-H) . The laminin-binding integrin α6 was localized at the basal surface of the mural trophectoderm in WT and Lamc1 EQ/EQ blastocysts irrespective of the laminin deposition in E4.0 (Fig 3C and D ) and E4.3 ( Fig 3G and H) blastocysts. To further examine the BM development in blastocysts, E3.5 blastocysts were flushed out from the uterus and cultured ex vivo for 48 h. In both ex vivo-cultured Lamc1 EQ/+ and Lamc1
EQ/EQ
blastocysts, laminins were densely deposited at the basal surface of the mural trophectoderm, where another BM component, perlecan, was colocalized ( Fig 3I and J) . These findings indicate that the preimplantation development of Lamc1 EQ/EQ embryos was normal according to their morphology, laminin deposition, and BM formation. It has been reported that deficiency of BM formation in embryoid bodies derived from β1 integrin-null mouse embryonic stem (ES) cells (Aumailley et al, 2000; Li et al, 2002) can be rescued by exogenous addition of laminin-111 in vitro (Li et al, 2002) . Because the BM assembly rescued by exogenous laminin-111 was blocked by the addition of the E3 fragment of laminin-111, but not the E8 fragment, E3-binding non-integrin receptors (e.g., dystroglycan, syndecan, and sulfated glycolipids) play dominant roles in the BM assembly of laminins. The dispensability of integrin binding of laminins in BM formation shown here using ex vivo-cultured Lamc1 EQ/EQ blastocysts is consistent with these previous findings.
Nevertheless, we cannot exclude the possibility that γ1 EQ mutation affects the BM assembly of laminins, which is not discernible at the level of conventional histology, thereby contributing to the phenotype of Lamc1 EQ/EQ embryos.
Because no apparent abnormalities in morphology and laminin deposition were observed in the Lamc1 EQ/EQ blastocysts, we investigated the early postimplantation development at E5.5 by immunofluorescence (Fig 3K-O) . Expression of Oct4 and Cdx2, markers for the epiblast and extraembryonic ectoderm, respectively, was detected in Lamc1 EQ/EQ embryos and in the control WT/ Lamc1 EQ/+ littermates (Fig 3M and N) . Visceral endoderm and parietal endoderm cells were also observed in Lamc1 EQ/EQ sections ( Fig 3O) . Thus, both embryonic and extraembryonic cell fate decisions occurred in Lamc1 EQ/EQ embryos. RM, which was stained with an anti-laminin-α1 antibody, was formed in control WT and Lamc1 EQ/+ heterozygotes at E5.5 (Fig 3K) . RM was also formed in Lamc1 EQ/EQ homozygotes at E5.5 (Fig 3L) , but showed severe disorganization by E7.5 (Fig 2J and K) . These findings indicate that RM formation was not affected in Lamc1 EQ/EQ mice until at least E5.5. It was previously shown in vivo that RM formation requires α1-containing laminins and dystroglycan (Williamson et al, 1997; Miner et al, 2004) . However, the deficient RM formation observed in Lamc1 EQ/EQ mice was different from that in laminin-α1 or dystroglycan knockout mice because the RM was initially formed in Lamc1 EQ/EQ mice.
γ1C-Glu-dependent integrin binding is indispensable for postimplantation development of extraembryonic tissues
Although cell differentiation and BM formation appeared unaffected at E5.5, Lamc1 EQ/EQ embryos were smaller than control WT/ Lamc1 EQ/+ embryos (Fig 3M and N) and exhibited poor development of extraembryonic tissues. The parietal yolk sac in Lamc1 EQ/EQ embryos also appeared smaller than that in WT/Lamc1 EQ/+ embryos (Fig 3M and N) . Therefore, we investigated the development of the parietal yolk sac by measuring the RM length on sections by quantitative image analysis (Fig 3P and Q) . After implantation at E5.5, the parietal yolk sac in WT and Lamc1 EQ/+ zygotes grew expansively and the RM length reached 452 ± 83 μm when measured on sections. By contrast, the RM length in Lamc1 EQ/EQ homozygotes was 217 ± 41 μm at E5.5, being significantly smaller than that in control embryos. These findings clearly showed that the expansive growth of the parietal yolk sac was defective in Lamc1 EQ/EQ homozygotes. Interestingly, the extraembryonic ectoderm was dissociated from its BM in Lamc1 EQ/EQ E5.5 zygotes (Fig 3N) , whereas that in the control WT/Lamc1 EQ/+ zygotes was tightly associated with the BM (Fig 3M) . The embryonic part of Lamc1 EQ/EQ embryos was not critically affected, as the epiblast and visceral endoderm remained associated with their laminin-α5-positive BMs (Fig 3O) . These results indicated that postimplantation development of extraembryonic tissues was critically dependent on lamininintegrin interactions through γ1C-Glu. No single α3, α6, or α7 integrin knockout mice were reported to exhibit early postimplantation defects (Georges-Labouesse et al, 1996; Kreidberg et al, 1996; Flintoff-Dye et al, 2005) . Because integrin α3 and α6 are dispensable for early postimplantation development, as shown by α3, α6 double-knockout mice (De Arcangelis et al, 1999 ) early postimplantation development is probably secured by cooperative functioning of α7 integrin with α3 and/or α6 integrins. It is, therefore, likely that integrin α7 functions cooperatively with α3 and/or α6 integrins in extraembryonic tissues because integrin α7 is expressed in the trophectoderm-derived extraembryonic tissues (Klaffky et al, 2001 ).
Conditional γ1 EQ knock-in mice as a tool for investigating the roles of laminin-integrin interactions in adult tissues
The above results clearly showed that the Lamc1 EQ knock-in allele is a valuable tool for investigating the roles of laminin-integrin interactions in vivo, although homozygotes die at the early postimplantation stage. Based on these results, we tried to develop a conditional knock-in mouse strain in which γ1C-Glu-dependent integrin binding can be ablated on demand. By homologous recombination in ES cells, we generated another Lamc1 mutant allele, Lamc1 cEQ , in which exon 28 was floxed and an additional EQmutated exon 28 was located in its 39 downstream (Fig 4A and B) . Lamc1 cEQ/cEQ homozygous mice were obtained according to the expected Mendelian ratio (Fig 4C) and appeared healthy and fertile.
Because the γ1 EQ knock-in mice showed embryonic lethality at the early developmental stage (Fig 2C) , we determined whether tissue-specific ablation of γ1C-Glu-dependent laminin-integrin interactions is available while preventing embryonic lethality. We introduced the Tie2-cre transgene (Kisanuki et al, 2001 ), expressing Cre recombinase in an endothelial cell-specific manner, into the Lamc1 cEQ/cEQ genetic background, and examined whether integrin binding to laminins was ablated in blood vessels. When adult retinal sections were probed with recombinant integrin α3β1, recombinant integrin binding to blood vessel BMs was observed in control Lamc1 cEQ/cEQ mice (Fig 4D-F) , but not in Tie2-cre;Lamc1 cEQ/ cEQ mice (Fig 4G-I) , consistent with blood vessel-specific introduction of the γ1 EQ mutation. As Tie2-cre;Lamc1 cEQ/cEQ mice were obtained according to the expected Mendelian ratio (Fig 4J) , conditional ablation of γ1C-Glu-dependent laminin-integrin binding in vivo was shown to be feasible. Here, we have revealed the significance of γ1C-Glu in the interactions of laminins with α3, α6, and α7 integrins by in vitro binding assays and by generating γ1 EQ knock-in mice. We have further developed a conditional γ1 EQ knock-in system in mice. Although laminin-integrin interactions have been extensively studied by in vitro analyses at the molecular and/or cellular levels, it has been difficult to verify the in vitro results in vivo. Our conditional γ1 EQ knock-in system in mice will be a valuable tool for investigating the roles of laminin-integrin interactions in various physiological and pathological situations in vivo.
Materials and Methods

Antibodies and reagents
Rat monoclonal antibodies (mAbs) against mouse laminin α1 (5B7-H1) and α5 (M5N8-C8) were produced as described (Manabe et al, 2008) . Mouse mAbs against human laminin α1 (5A3), α5 (15H5), β1 (DG10), and γ1 (C12SW) were produced as described previously (Kikkawa et al, 1998; Ido et al, 2007) . Mouse mAbs against human laminin β1 were purchased from Enzo Life Sciences. Rabbit polyclonal antibody (pAb) against Velcro (ACID/BASE coiled-coil) peptides was produced as described (Takagi et al, 2001 ). Mouse anti-FLAG mAb, rabbit anti-laminin pAb, and BSA were obtained from Sigma-Aldrich; rat anti-perlecan mAb was purchased from Merck Millipore; rat anti-mouse integrin-α6 mAb (GoH3) was from BD Biosciences; mouse anti-Cdx2 mAb was from Biocare; rabbit anti-Oct4 pAb was from Santa Cruz Biotechnology; HRP-conjugated donkey anti-mouse IgG and Cy3-conjugated anti-rat IgG were from Jackson ImmunoResearch; Alexa 488-conjugated goat anti-rabbit IgG, Alexa 546-conjugated goat anti-rat IgG, Alexa 405-conjugated goat anti-rabbit IgG, Alexa 488-conjugated goat anti-rat IgG, and Alexa 546-conjugated goat anti-mouse IgG were from Invitrogen; HRP-conjugated streptavidin was from Thermo Fisher Scientific. Rat anti-cytokeratin-8 mAb (TROMA-I), developed by Philippe Brulet and Rolf Kemler, was obtained from the Developmental Studies Hybridoma Bank. The antibody dilutions used are shown in Table  S1 . Bovine type I and type IV collagens were obtained from Nippi Inc. Mouse laminin-111 was prepared from mouse Engelbreth-HolmSwarm tumor as described previously (Nishiuchi et al, 2006) . Fibronectin was purified from human plasma by gelatin affinity chromatography as described previously (Sekiguchi & Hakomori, 1983) .
Expression vectors
Expression vectors for human laminin α1, α5, β1, and FLAG-tagged γ1 chains were prepared as described (Hayashi et al, 2002; Ido et al, 2004 Ido et al, , 2006 Ido et al, , 2008 . The FLAG tag of laminin γ1 was located just after the N-terminal signal peptide cleavage site to facilitate purification of recombinant laminins. Expression vectors for the extracellular domains of the human integrin α1, α2, α3, α6, α7x1, α7x2, and α9 subunits were constructed as described (Nishiuchi et al, 2006; SatoNishiuchi et al, 2012; Jeong et al, 2013) . Expression vectors for the extracellular domains of the human integrin αv, β1, β3, and β4 subunits were kindly provided by Dr. Junichi Takagi (Institute for Protein Research, Osaka University) (Takagi et al, 2001 (Takagi et al, , 2002a ). An expression vector for the extracellular domains of human integrin α5 was constructed in a similar manner to those of other integrin α subunits (Nishiuchi et al, 2006; Sato-Nishiuchi et al, 2012; Jeong et al, 2013 ). An expression vector for the extracellular domain of human integrin β5 was prepared using a cDNA amplified from RNA extracted from T98G human glioblastoma cells. Expression vectors for recombinant human vitronectin with an N-terminal FLAG tag and the C-terminal fragment of mouse polydom were prepared as described (Sato-Nishiuchi et al, 2012; Ozawa et al, 2016) .
Expression and purification of recombinant proteins
Recombinant human laminin-111, laminin-511, and their EQ mutants were produced using a FreeStyle 293 Expression System (Thermo Fisher Scientific) as described (Ido et al, 2004) . The conditioned media were passed over ANTI-FLAG M2 Affinity Gel (Sigma-Aldrich).
After washing with 20 mM Tris-buffered saline without divalent cations (TBS), bound proteins were eluted with 100 μg/ml FLAG peptide (Sigma-Aldrich) and dialyzed against TBS. Purified proteins were verified by 4% SDS-PAGE under reducing conditions (Fig S1) .
Other recombinant proteins (integrin α1β1, α2β1, α3β1, α6β1, α7x1β1, α7x2β1, α9β1, αvβ3, αvβ5, and α5β1, and vitronectin and C-terminal fragment of polydom) were produced using the FreeStyle 293 Expression System and purified on ANTI-FLAG M2 Affinity Gel as described above. Protein concentrations were determined with a BCA protein assay kit (Thermo Fisher Scientific) using BSA as a standard.
Laminin secretion assay
Recombinant human laminin-111, laminin-511, and their EQ mutants were produced using the FreeStyle 293 Expression System as described above. Conditioned media were recovered at 3 d after transfection and applied to SDS-PAGE and subsequent Western blot analyses.
Western blotting
E7.5 embryos were lysed in 20 μl of SDS-PAGE sample buffer under nonreducing conditions. Purified laminins were prepared as samples for SDS-PAGE under reducing conditions. Conditioned media of human 293 cells were mixed with equal amounts of 2× SDS-PAGE sample buffer under nonreducing conditions. Proteins were separated by 4% SDS-PAGE and transferred onto nitrocellulose membranes. The membranes were immunoblotted with the indicated primary Abs and goat anti-rabbit or anti-mouse IgG secondary antibodies conjugated with HRP (Jackson ImmunoResearch Laboratories). The bound primary antibody was visualized with an Amersham ECL Prime Western blotting detection reagent kit (GE Healthcare).
Integrin binding assays
Solid-phase assays for binding of integrins to laminins, collagens, vitronectin, and polydom were carried out as described . Briefly, 96-well microtiter plates were coated with recombinant proteins (laminins, vitronectin, and polydom, 5 nM; collagens, 10 μg/ml) overnight at 4°C, blocked with 3% BSA for 1 h at room temperature, and incubated with 30 nM integrins for 3 h at room temperature in the presence of 1 mM Mn
2+
. Bound integrins were detected after sequential incubations with biotinylated rabbit anti-Velcro pAb and HRP-conjugated streptavidin. The amounts of recombinant laminins, vitronectin, and polydom adsorbed on the plates were quantified by enzyme-linked immunosorbent assays using an anti-FLAG M2 mAb to confirm equality of the adsorbed proteins.
Mice
The B6.Cg-Tg(CAG-cre)CZ-MO2Osb mouse strain expressing Crerecombinase under the CAG promoter (BRC No. 01828) was provided by the RIKEN BioResource Center with support from the National BioResource Project of the Ministry of Education, Culture, Sports, Science and Technology, Japan. The B6-Tg(CAG-FLPe)36 mouse strain expressing Flp-recombinase under the CAG promoter (BRC No. 01834) (Kanki et al, 2006) was also provided by RIKEN BioResource Center with support from the National BioResource Project of the Ministry of Education, Culture, Sports, Science and Technology, Japan. The B6.Cg-Tg(Tek-cre)1Ywa/J (Tie2-cre) mouse strain expressing Cre-recombinase under the Tek (Tie2) promoter (Kisanuki et al, 2001 ) was provided by Jackson Laboratory.
To generate Lamc1 EQ knock-in mice, a knock-in vector was constructed to include the 2-kb upstream Lamc1 genomic sequence, a neomycin-resistance gene sandwiched by loxP sequences, the 5-kb downstream Lamc1 genomic sequence, and a thymidine kinase gene, as shown schematically in Fig 2A. To introduce the γ1 EQ mutation, the 5-kb genomic sequence was point-mutated by overlap-extension PCR. The knock-in vector was introduced into strain 129 mouse ES cells. The resulting targeted clones were verified by PCR and Southern blotting and injected into C57Bl/6 blastocysts to obtain chimeric mice. Male chimeric mice that transmitted the mutated Lamc1 gene through the germline were crossed with C57Bl/6 female mice (Japan SLC) to generate Lamc1 EQ(Neo) mice. The Lamc1 EQ(Neo)/+ heterozygotes were crossed with B6.Cg-Tg(CAG-cre)CZ-MO2Osb mice to obtain Lamc1 EQ/+ heterozygotes, in which the neomycin-resistance gene was removed. The Lamc1 EQ/+ heterozygotes were crossed to obtain Lamc1 EQ/EQ homozygotes and WT littermates. E0.5 was defined as noon on the day of plug detection. To generate Lamc1 cEQ mice, a knock-in vector was constructed as follows. The vector included the 2-kb upstream Lamc1 genomic sequence, a neomycin-resistance gene sandwiched by loxP sequences, the 5-kb downstream Lamc1 genomic sequence, and a thymidine kinase gene, as shown schematically in Fig 4A. To introduce the γ1 EQ mutation, the 5-kb genomic sequence was point-mutated by overlap-extension PCR. The knock-in vector was introduced into strain 129 mouse ES cells. The resulting targeted clones were verified by PCR and Southern blotting, and injected into C57Bl/6 blastocysts to obtain chimeric mice. Male chimeric mice that transmitted the mutated Lamc1 gene through the germline were crossed with C57Bl/6 female mice to generate Lamc1 The mice were kept in a specific pathogen-free environment under stable conditions of temperature and light (lights ON at 08:00 and OFF at 20:00). All mouse experiments were performed in compliance with our institutional guidelines and were approved by the Animal Care Committee of Osaka University.
Ex vivo blastocyst culture E3.5 blastocysts were flushed from the uterus with flushing-holding medium (Lawitts & Biggers, 1993) , washed with potassium simplex optimization medium (Lawitts & Biggers, 1993) , and cultured in a hanging drop of potassium simplex optimization medium at 37°C for 48 h under 5% CO 2 .
Genotyping
Genomic DNAs were extracted with DirectPCR Lysis Reagent (Viagen Biotech) at 55°C overnight and then heat-denatured at 95°C for 10 min.
The genotypes of Lamc1 EQ postnatal mice and whole-mount embryos were determined by genomic PCR using the primer pair 59-AAGCAGGAGGCAGCCATCATGGACT-39 and 59-GGAAGATGCCGTGACT-TCAGGCAAA-39. WT DNA and Lamc1 EQ DNA both gave PCR products of approximately 400 bp. The PCR products were digested with TaqI and separated by 1.8% agarose gel electrophoresis. Although the PCR product derived from the WT allele was digested into bands of 280 and 120 bp, the PCR product derived from the Lamc1 EQ allele remained undigested because the γ1 EQ mutation abolished the TaqI site. Because it is difficult to isolate embryonic tissues without contamination by surrounding maternal tissues, the genotypes of sectioned embryos were determined by their integrin-binding activity in situ (Kiyozumi et al, 2014) . For sectioned E5.5-E7.5 embryos, the genotypes were determined by in situ binding of recombinant integrin α7x2β1. Embryos that showed integrin α7x2β1 binding to anti-laminin immunoreactive sites were genotyped as WT or Lamc1 EQ/+ , whereas those that did not show α7x2β1 binding were genotyped as Lamc1 EQ/EQ . As Lamc1 EQ/+ mice appeared normal, we did not distinguish Lamc1 EQ/+ from WT after genotyping by in situ integrin binding and their genotypes are presented as WT or Lamc1 EQ/+ in the relevant figures.
The genotypes of Lamc1 cEQ mice were determined by genomic PCR using the primer pair 59-TTACCAAGTCACCTTCTTCAGCATAAGCGA-39 and 59-GTACATGCGTGTCTGCATGAATGCCATA-39. The sizes of the PCR products from the WT and Lamc1 cEQ alleles were 234 and 423 bp, respectively. The genotypes of the Tie2-cre transgene were determined by genomic PCR using the primer pair 59-GTTTCACTGGTTATGCGGCGG-39 and 59-TTCCAGGGCGCGAGTTGATAG-39. The size of the PCR product was 450 bp.
In situ integrin binding
In situ integrin binding was performed as described (Kiyozumi et al, , 2014 . Frozen sections of mouse embryos were blocked with blocking buffer (3% BSA, 25 mM Tris-HCl pH 7.4, 100 mM NaCl, and 1 mM MnCl 2 ) for 30 min at room temperature, and then incubated with 3 μg/ml of recombinant integrin α7x2β1 and rat anti-laminin-α1 mAb (5B7-H1) in blocking buffer at 4°C overnight. The sections were washed three times with wash buffer (25 mM Tris-HCl pH 7.4, 100 mM NaCl, and 1 mM MnCl 2 ) for 10 min at room temperature, and incubated with 0.5 μg/ml of rabbit anti-Velcro pAb in blocking buffer at room temperature for 2 h. After washing with wash buffer, the sections were incubated with Alexa 488-conjugated goat antirabbit IgG and Cy3-conjugated anti-rat IgG. The nuclei were stained with Hoechst 33342. After washing with wash buffer, the sections were mounted in PermaFluor (Thermo Scientific Shandon) and visualized with an LSM510 laser confocal microscope (Carl Zeiss).
Immunofluorescence
Whole-mount immunofluorescence of blastocysts was performed as follows: Blastocysts were fixed in 4% paraformaldehyde in PBS at 4°C for 10 min. The fixed blastocysts were washed with PBS, permeabilized with 0.1% Triton X-100 in PBS at 4°C for 10 min, and incubated with a rabbit anti-laminin pAb and rat anti-perlecan mAb or rat anti-mouse integrin-α6 mAb (GoH3) diluted in 0.1% Tween-20/PBS (TPBS) at 4°C overnight. The embryos were then washed three times with TPBS for 10 min, and incubated with Alexa 546-conjugated goat anti-rabbit IgG and Alexa 488-conjugated goat anti-rat IgG. The nuclei were stained with Hoechst 33342 for 2 h. After three washes with TPBS for 10 min, the blastocysts were placed in a small drop of PBS covered with mineral oil on a coverslip, and visualized under the LSM510 confocal microscope.
Immunofluorescence of sectioned tissues was also performed. Frozen sections of mouse embryos were fixed in 4% paraformaldehyde in PBS at 4°C for 10 min, blocked with 3% BSA/TPBS at 4°C for 30 min, and incubated at 4°C overnight with the following antibodies diluted in 3% BSA/TPBS: mixture of rabbit anti-laminin pAb and rat anti-cytokeratin-8 mAb (TROMA-I); mixture of rat anti-laminin-α1 mAb, mouse anti-Cdx2 mAb, and rabbit anti-Oct4 pAb; or mixture of rabbit anti-laminin pAb and rat anti-laminin-α5 mAb (M5N8-C8). The sections were washed three times with TPBS for 10 min, and incubated at 4°C for 2 h with the following secondary antibodies: Alexa 488-conjugated goat anti-rabbit IgG and Alexa 546-conjugated goat anti-rat IgG; or Alexa 405-conjugated goat anti-rabbit IgG, Alexa 488-conjugated goat anti-rat IgG, and Alexa 546-conjugated goat anti-mouse IgG. The nuclei were stained with Hoechst 33342 if necessary. After three washes with TPBS for 10 min, the sections were mounted in PermaFluor and visualized using the LSM510 laser confocal microscope.
Frozen sections of 8-wk-old mouse retina were air-dried for 30 min at room temperature, fixed with cold acetone at −30°C for 15 min, washed with TBS, blocked with blocking buffer (1% BSA, 25 mM Tris-HCl pH 7.4, 100 mM NaCl, and 1 mM MnCl 2 ) for 30 min at room temperature, and incubated with 3 μg/ml of recombinant integrins and specified antibodies in blocking buffer at 4°C overnight. The sections were washed three times with wash buffer (25 mM Tris-HCl pH 7.4, 100 mM NaCl, and 1 mM MnCl 2 ) for 10 min at room temperature, and incubated with 0.5 μg/ml of rabbit anti-Velcro pAb and anti-laminin-α5 mAb in blocking buffer at room temperature for 2 h. After washing with wash buffer, the sections were incubated with Alexa 488-conjugated goat anti-rabbit IgG and Alexa 546-conjugated anti-rat IgG. The nuclei were stained with Hoechst 33342. After washing with wash buffer, the sections were mounted in PermaFluor and visualized using the LSM510 laser confocal microscope.
The LSM510 laser confocal microscope was equipped with LDAchroplan (20×, NA 0.4) and Plan-Neofluar (10×, NA 0.3; 40×, NA 0.75) objective lenses at room temperature. The imaging medium was air. The LSM510 PASCAL software (Carl Zeiss) was used for image collection. Each set of stained samples was processed under identical gain and laser power settings. Each set of obtained images was processed under identical brightness and contrast settings, which were adjusted by the LSM image browser (Carl Zeiss) and ImageJ software (Abràmoff et al, 2004) for clear visualization of BMs. At least four pairs of sections for mutant mice and their control littermates were examined, and similar results were obtained.
Image analysis
The length of the RM was measured on anti-laminin immunofluorescencestained images of E5.5 egg cylinders using ImageJ software (see also Fig 3P) .
